TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303).

Jane R Schwebke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.